If our results are validated, the expression of the SEMA3F-NRP2 axis could be used as a biomarker predicting the risk of occult lymph node metastasis, with elective neck dissections being indicated exclusively for patients at higher risk. This evidence concerns the gene NRP2 and metastatic malignant neoplasm in the lymph nodes.